High osmolarity antimicrobial composition containing one or more organic solvents
A composition that can solvate biofilms and disrupt bacterial cell walls acts to both kill the bacteria by cell lysis and remove the biofilm. This solvent-containing composition is effective against a broad spectrum of microbes and can be used on a variety of surfaces, both living and inanimate. The polarity of the solvent component of the composition is lower than that of pure water so that the composition exhibits increased efficacy in solvating the macromolecular matrix of a biofilm and in penetrating bacterial cell walls.
1. A method for treating a dermal wound, said method comprising applying to said wound a liquid wash composition adapted for dermal application, said composition consisting of
a) a solvent component exhibiting a δ p value of from 13.7 to 15.4 MPa 1/2 that consists of water and one or more C 1 -C 16 acyclic alcohols; and
b) a solute component that comprises cationic surfactant, dissociation products of at least one organic polyacid and dissociation products of at least one salt of at least one organic acid,
said composition having a pH of greater than about 3 but less than 5.0 and an effective solute concentration of from 1 to 2.33 Osm/L.
2. The method of claim 1 wherein said composition exhibits a pH of less than 4.6.
3. The method of claim 2 wherein said composition exhibits a pH of less than 4.4.
4. The method of claim 3 wherein said composition exhibits a pH of less than 4.2.
5. The method of claim 1 wherein said one or more C 1 -C 16 acyclic alcohols of said composition comprises ethanol.
6. The method of claim 5 wherein said one or more C 1 -C 16 acyclic alcohols is ethanol.
7. The method of claim 1 wherein said at least one polyacid comprises citric acid.
8. The method of claim 7 wherein said at least one salt of at least one organic acid comprises a citrate.
9. The method of claim 1 wherein said composition has an effective solute concentration of at least 1.5 Osm/L.
10. The method of claim 9 wherein said composition has an effective solute concentration of at least 1.75 Osm/L.
11. The method of claim 7 wherein said at least one polyacid is citric acid.
12. The method of claim 8 wherein said at least one salt of at least one organic acid is a citrate.
13. A process for treating a dermal wound, said process comprising applying to said wound a liquid wash composition adapted for dermal application, said composition consisting of
a) a solvent component exhibiting a δ p value of from 13.7 to 15.4 MPa 1/2 that consists of water and ethanol; and
b) a solute component that consists of cationic surfactant, dissociation products of at least one organic polyacid and dissociation products of at least one salt of at least one organic polyacid,
said composition having a pH of greater than about 3 but less than 4.4 and an effective solute concentration of from 1 to 2.33 Osm/L.
14. The process of claim 13 wherein said at least one polyacid comprises citric acid.
15. The process of claim 14 wherein said at least one salt of at least one organic acid comprises a citrate.
16. The process of claim 14 wherein said at least one polyacid is citric acid.
17. The process of claim 15 wherein said at least one salt of at least one organic acid is a citrate.
18. A liquid wound wash composition adapted for dermal application, said composition consisting of
(1) a solvent component exhibiting a δ p value of from 13.7 to 15.4 MPa 1/2 that consists of water and ethanol; and
(2) a solute component that consists of cationic surfactant, dissociation products of at least one polyacid and dissociation products of at least one salt of at least one polyacid,
said composition having a pH of greater than about 3 but less than 4.4 and an effective solute concentration of from 1 to 2.33 Osm/L.
19. The liquid wound wash composition of claim 18 wherein said solute component consists of cationic surfactant, dissociation products of one polyacid and dissociation products of one salt of a polyacid.
20. The liquid wound wash composition of claim 19 wherein said solute component consists of benzalkonium chloride, citric acid and a citrate.
21. The liquid wound wash composition of claim 18 wherein said composition has an effective solute concentration of at least 1.5 Osm/L.
22. The liquid wound wash composition of claim 21 wherein said composition has an effective solute concentration of at least 1.75 Osm/L.
23. The liquid wound wash composition of claim 20 wherein said benzalkonium chloride constitutes no more than 0.13 weight percent of said composition.